Itraconazol Heumann (Itraconazole)

Itraconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform required for converting lanosterol to ergosterol. Blocking this step prevents ergosterol formation, disrupting fungal cell membrane integrity and leading to impaired growth or death of the organism. Human cells are less affected because the drug has lower affinity for the human counterpart of the enzyme.

The dosage of itraconazole is individualized by the prescribing clinician based on the specific infection, severity, patient weight, renal and hepatic function, and potential drug interactions. Physicians determine the appropriate strength, frequency, and duration of therapy, and patients should follow the prescribed regimen exactly as instructed.

Safety data for itraconazole in pregnancy and lactation are limited. It is generally classified as contraindicated or to be used only when the potential benefit outweighs the risk to the fetus or infant. Women who are pregnant, planning pregnancy, or nursing should discuss alternative treatments with their healthcare provider before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Itraconazol Heumann. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Compared with polyene agents such as amphotericin B, itraconazole offers oral administration and a more favorable safety profile, though it has notable drug‑interaction potential. Against newer azoles like voriconazole, itraconazole provides broader activity against dermatophytes and certain dimorphic fungi but may have lower bioavailability for some indications. Choice of therapy depends on infection type, patient comorbidities, and susceptibility patterns.

Itraconazol Heumann should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture, light, and humidity. Keep the product out of reach of children and avoid storing it in bathrooms or other damp environments. Do not freeze the medication, and discard any tablets that appear discolored or damaged.

The medication is taken orally, usually with food or a full glass of water to enhance absorption. Patients should swallow the tablets whole and avoid crushing or chewing them unless specifically instructed by a healthcare professional. The exact dosing schedule, including frequency and duration, is determined by the prescriber based on the infection being treated.

Serious adverse events include hepatotoxicity, which may present as elevated liver enzymes or severe liver injury, and congestive heart failure due to negative inotropic effects. Rare but critical reactions such as severe allergic responses, arrhythmias, and visual disturbances have also been reported. Patients should be monitored regularly for liver function, cardiac status, and any signs of hypersensitivity throughout treatment.

Itraconazole is contraindicated in individuals with known hypersensitivity to itraconazole or any other azole antifungal. It should be avoided in patients with established heart failure, severe hepatic impairment, or those receiving medications that strongly induce its metabolism (e.g., rifampin) without appropriate dose adjustment. Pregnant or breastfeeding women should only use it when the therapeutic benefit justifies potential risks, and all decisions must be guided by a qualified healthcare professional.